12-52515040-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PVS1_Moderate
The NM_000424.4(KRT5):c.1675C>T(p.Arg559*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000631 in 1,300,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000424.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT5 | NM_000424.4 | c.1675C>T | p.Arg559* | stop_gained | 9/9 | ENST00000252242.9 | NP_000415.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT5 | ENST00000252242.9 | c.1675C>T | p.Arg559* | stop_gained | 9/9 | 1 | NM_000424.4 | ENSP00000252242.4 | ||
KRT5 | ENST00000552952.1 | n.600C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000851 AC: 10AN: 117466Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.0000578 AC: 14AN: 242146Hom.: 0 AF XY: 0.0000534 AC XY: 7AN XY: 131040
GnomAD4 exome AF: 0.0000609 AC: 72AN: 1183020Hom.: 0 Cov.: 42 AF XY: 0.0000562 AC XY: 33AN XY: 586770
GnomAD4 genome AF: 0.0000851 AC: 10AN: 117466Hom.: 0 Cov.: 26 AF XY: 0.0000359 AC XY: 2AN XY: 55786
ClinVar
Submissions by phenotype
not provided Pathogenic:1Benign:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 25, 2023 | Identified in a patient with localized EBS in published literature (Bchetnia et al., 2012); Nonsense variant predicted to result in protein truncation, as the last 32 amino acids are lost; This variant is associated with the following publications: (PMID: 31589614, 21877134) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 12, 2017 | - - |
KRT5-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 21, 2023 | The KRT5 c.1675C>T variant is predicted to result in premature protein termination (p.Arg559*). This variant was reported to occur de novo in a 51 year old individual with moderate localized epidermolysis bullosa simplex (Bchetnia et al 2012. PubMed ID: 21877134). The c.1675C>T variant is located in the last exon of KRT5 and may not result in nonsense-mediated decay. Other frameshift variants reported in this last exon have been reported with autosomal dominant inheritance, but many of them result in amino acid substitutions and extension of the protein (Yalici-Armagan. 2020. PubMed ID: 31965605; Kim. 2017. PubMed ID: 28561874). This variant is reported in 0.011% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-52908824-G-A). We interpret this variant this variant as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at